MacroGenics
MGNX
#9332
Rank
C$0.21 B
Marketcap
C$3.35
Share price
0.84%
Change (1 day)
49.91%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$0.42 Billion

According to MacroGenics's latest financial reports the company's total liabilities are C$0.42 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$0.27 B31.92%
2024-12-31C$0.20 B8.04%
2023-12-31C$0.19 B2.93%
2022-12-31C$0.18 B54.16%
2021-12-31C$0.12 B15.35%
2020-12-31C$0.10 B-1.2%
2019-12-31C$0.10 B-12.05%
2018-12-31C$0.12 B29.55%
2017-12-31C$93.84 M64.27%
2016-12-31C$57.12 M-10.34%
2015-12-31C$63.71 M4.38%
2014-12-31C$61.04 M22.35%
2013-12-31C$49.89 M-19.06%
2012-12-31C$61.63 M-24.41%
2011-12-31C$81.54 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$161.58 B 38,123.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$151.47 B 35,731.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$117.30 B 27,649.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$52.56 B 12,334.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$122.70 B 28,927.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$91.26 B 21,489.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.30 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA